You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Suppliers and packagers for POTASSIUM CHLORIDE 20MEQ IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


POTASSIUM CHLORIDE 20MEQ IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Otsuka Icu Medcl POTASSIUM CHLORIDE 20MEQ IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER potassium chloride; sodium chloride INJECTABLE;INJECTION 019686 NDA ICU Medical Inc. 0990-7115-09 12 POUCH in 1 CASE (0990-7115-09) / 1 BAG in 1 POUCH / 1000 mL in 1 BAG 2019-11-01
Otsuka Icu Medcl POTASSIUM CHLORIDE 20MEQ IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER potassium chloride; sodium chloride INJECTABLE;INJECTION 019686 NDA ICU Medical Inc. 0990-7116-09 12 POUCH in 1 CASE (0990-7116-09) / 1 BAG in 1 POUCH / 1000 mL in 1 BAG 2019-12-01
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for Potassium Chloride 20mEq in Sodium Chloride 0.9% in Plastic Container

Last updated: August 7, 2025

Introduction

The pharmaceutical market for electrolytes is indispensable in clinical, hospital, and emergency settings, given the critical role of maintaining electrolyte balance. Among these, Potassium Chloride (KCl) at a concentration of 20mEq in a 0.9% sodium chloride (NaCl) solution, packaged in plastic containers, is a standard intravenous (IV) electrolyte replenisher. Identifying reliable suppliers for this formulation is crucial for healthcare providers demanding high-quality, regulatory-compliant products. This article offers an exhaustive overview of current key suppliers, focusing on global and regional manufacturers known for manufacturing this specific formulation.

Market Overview of Potassium Chloride in Sodium Chloride 0.9% Solutions

Potassium Chloride in 0.9% Sodium Chloride solution, also referred to as normal saline with added potassium, is a routine product used to correct hypokalemia, maintain electrolyte balance, and support various clinical interventions. The global demand for such formulations has surged over recent years, driven by expanding healthcare infrastructure, increased prevalence of electrolyte disturbances, and the growing use of IV therapies.

Manufacturers typically produce these solutions under strict regulatory standards, such as GMP (Good Manufacturing Practice), to ensure safety and efficacy.

Leading Suppliers of Potassium Chloride 20mEq in Sodium Chloride 0.9% in Plastic Containers

1. Baxter International Inc.

Overview:
Baxter is a leading global provider of sterile IV solutions, including electrolyte products. Their portfolio features pre-filled and large-volume IV solutions, including potassium chloride solutions in sodium chloride.

Product Details:

  • Packaging Options: Plastic bottles (typically 250 mL, 500 mL, or 1000 mL).
  • Compliance: FDA-approved, CE-marked, and compliant with international standards.
  • Distribution: Worldwide, with extensive supply chains in North America, Europe, and Asia.

Reputation & Capacity:
Baxter’s manufacturing prowess and quality controls position it as a preferred supplier for hospitals and pharmaceutical companies seeking reliable electrolyte solutions.

2. B. Braun Melsungen AG

Overview:
B. Braun offers a broad spectrum of IV fluids, including potassium chloride in sodium chloride 0.9%, produced under stringent regulatory environments.

Product Details:

  • Packaging: Plastic containers (250 mL to 1000 mL).
  • Features: Compatible with standard IV infusion sets, assured stability, and shelf life.
  • Certifications: ISO, GMP, and compliant with both European and US regulatory standards.

Global Reach:
B. Braun’s large manufacturing network supports consistent supply across multiple regions, emphasizing product purity and batch-to-batch uniformity.

3. Fresenius Kabi AG

Overview:
Fresenius Kabi is a prominent manufacturer of IV drug solutions, including electrolyte replenishment products.

Product Details:

  • Packaging: Plastic containers suitable for IV infusion.
  • Quality Standards: Adheres to USFDA, EUGMP, and other regulatory standards.
  • Availability: Sold extensively in North America, Europe, and Asia-Pacific markets.

Key Strengths:
Fresenius is noted for its technological advances in aseptic manufacturing processes, ensuring high product safety.

4. Hospira (a Pfizer company)

Overview:
Hospira specializes in sterile injectable drugs and infusion solutions, with extensive lines of electrolyte products.

Product Details:

  • Packaging: Various volumes in plastic containers, including prefilled and flexible bottles.
  • Regulatory Compliance: USFDA-approved with international certifications.
  • Distribution Footprint: Major markets in North America, Latin America, and emerging economies.

5. MacoPharma (part of the Macau Pharmaceutical Group)

Overview:
MacoPharma manufactures and supplies electrolyte solutions and infusion fluids, catering to regional markets with high compliance standards.

Product Details:

  • Packaging: Plastic bottles, compatible with infusion pumps.
  • Regulatory Certificates: WHO-GMP, ISO compliance, and regional approvals.

6. Local and Regional Manufacturers

In addition to multinational corporations, various regional manufacturers in Asia-Pacific, Latin America, and Eastern Europe produce Potassium Chloride in Sodium Chloride solutions, often at competitive prices:

  • Fresenius Kabi India
  • HIS Pharmaceuticals (India)
  • China-based manufacturers like Jiangsu Hengrui Medicine

These manufacturers often cater to local hospitals and distributors, adhering to local GMP standards but may vary in global regulatory compliance.

Key Considerations When Selecting Suppliers

  • Regulatory Compliance: Ensure products meet local and international standards, such as USFDA, EMA, or WHO-GMP certifications.
  • Product Stability & Packaging: Confirm the suitability of plastic containers for IV administration, stability data, and expiry.
  • Supply Chain Reliability: Choose suppliers with robust logistics, especially in the context of global disruptions.
  • Pricing & Contract Terms: Evaluate cost-effectiveness, volume discounts, and contractual flexibility.
  • Reputation & Quality Track Record: Prioritize companies with proven safety profiles and consistent quality certifications.

Emerging Trends & Future Outlook

The electrolytes market is witnessing innovations like pre-filled syringes, ready-to-use formulations, and closed-system containers to reduce contamination risks. Manufacturers investing in process automation and sterilization enhancements are likely to strengthen their market position.

Furthermore, increasing demand in emerging markets and the expansion of hospital infrastructure promises continued growth for suppliers capable of scaling up production while maintaining quality.

Conclusion

Securing reliable suppliers for Potassium Chloride 20mEq in Sodium Chloride 0.9% in plastic containers requires thorough vetting of quality standards, regulatory compliance, and supply chain robustness. Leading global providers like Baxter, B. Braun, Fresenius Kabi, and Hospira remain prominent choices, backed by extensive regulatory approvals and manufacturing capacity. Regional manufacturers can also serve local needs efficiently, provided they meet necessary standards.

Healthcare organizations should prioritize suppliers with a proven track record for safety, consistency, and logistical reliability to ensure uninterrupted, high-quality electrolyte therapy.


Key Takeaways

  • Major global suppliers include Baxter, B. Braun, Fresenius Kabi, and Hospira, all recognized for compliance and manufacturing excellence.
  • Regional manufacturers can offer competitive pricing but require careful validation of regulatory adherence.
  • Packaging quality and compatibility with infusion systems are critical for safety.
  • Maintaining diversified supplier relationships minimizes supply risks amid global disruptions.
  • Staying informed about emerging formulations and technology advances enhances supply chain resilience.

FAQs

1. Are there specific licensing requirements for importing potassium chloride solutions?
Yes. Importers must comply with local regulatory agencies such as the FDA (USA), EMA (Europe), or respective national authorities, ensuring the products are approved and labeled appropriately.

2. What are the key safety features to consider in plastic containers for IV solutions?
Containers should be sterile, tamper-evident, made from inert, medical-grade plastics, and compatible with infusion systems to prevent contamination, degradation, or leaching.

3. How does the quality of regional manufacturers compare to global suppliers?
While many regional manufacturers meet local standards, global suppliers typically adhere to more rigorous international quality standards, but regional players can be suitable if certified accordingly.

4. Can these electrolyte solutions be used beyond hospital settings?
Yes. They are also used in clinics, emergency services, and in certain controlled outpatient care settings where sterile IV administration is required.

5. How should healthcare providers verify the authenticity of supplied potassium chloride solutions?
Verify certificates of analysis, batch records, and certification labels. Prefer suppliers that provide traceability and have transparent quality assurance processes.


Sources:

[1] Baxter International Inc. – Product information and regulatory compliance statements.
[2] B. Braun Melsungen AG – Official product catalog.
[3] Fresenius Kabi – Corporate website and product datasheets.
[4] Hospira (Pfizer) – USFDA approval documents.
[5] WHO-GMP guidelines and regional manufacturing standards.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.